2019
  • Selecção de dois participantes no curso intensivo IBD - ECCO 2020 Viena
    • Joana Roseira - CHUA
    • Mário Miranda - CHUC

2018
Bolsas de Doutoramento 2018/19
  • Uma bolsa concedida a Paula Cristina Ribeiro Fernandes de Sousa.
Projecto: Azathioprine and metabolites - pharmacokinetic and inflammatory implications

Bolsas de Investigação 2018/19
  • Duas bolsas concedidas no valor de 25.000,00€

Projectos premiados:
  1. "Targeting miR-21 in PSC-IBD patients" - André Santos
  2. "Pharmacological interventions upon ion sensing and transport mechanisms in fibrotic Crohn's disease" - Dina Cosme
  • Selecção de dois participantes no curso intensivo IBD - ECCO 2018 Copenhaga
    • Sónia Bernardo - CHLN Santa Maria
    • Gonçalo Nunes - Hospital Garcia de Orta


2017

Bolsas de Investigação 2017/18
  • Uma bolsa concedida no valor de 25.000,00€

Projecto premiado:
  1. "Azathioprine and metabolites - pharmacokinetic and inflammatory implications" - Paula Cristina Ribeiro Fernandes de Sousa
  • Selecção de dois participantes no curso intensivo IBD - ECCO 2017 Viena
    • Joana Carvalho - CHLN Santa Maria
    • Joana Castela - IPOLFG


2016

Bolsas de Investigação 2016/17
  • 4 bolsas concedidas no valor de 25.000,00€

Projectos premiados:
  1. "DEVELOPMENT OF A HISTOPATHOLOGICAL SCORE TO MESURE AND DECIPT INTESTINAL WALL INFLAMMATION AND FIBROSIS IN CD OF THE ILEUM - DIFICIL STUDY" - Helena Tavares de Sousa
  2. “PROSPECTIVE COHORT OF NEWLY DIAGNOSED CROHN'S DISEASE - Crohn's disease Observational Cohort Study" - Joana Torres
  3. “SWEET: GLYCANS AS NOVEL IMMUNOMODULATORS IN IBD” - Salomé Pinho
  4. “THE ROLE OF T LYMPHOCYTE DIFFERENTIATION IN IBD - ASSOCIATED COLORECTAL CARCINOMA” - José Carlos Machado



2015

Bolsas de investigação 2015/16
  • 4 bolsas concedidas no valor de 15.000,00€

Projectos premiados:
  1. "Role for the renin-angiotensin system in inflammatory bowel disease: mechanisms and translation" - MANUELA MORATO
  2. "Avaliação da expressão de glucagon-like peptide 2 and dipeptidil peptidase 4 em biópsias intestinais de doentes com DII versus controlos e em dois modelos celulares de inflamação intestinal"- PEDRO LOPES
  3. "Setting the basis for exploring the co-participation of adherent-invasive Escherichia coli and Mycobacterium avium subsp. paratuberculosis in Crohn's disease" – AMELIA ASSUNÇAO
  4. Alterações da coagulação numa população de doentes com doença inflamatória intestinal; Coagulation disorders in a population of patients with inflammatory bowel disease" – JULIANA PINHO


2014

Bolsas de investigação 2014/15
  • 6 bolsas concedidas no valor de 15.000,00€

Projectos premiados:
  1. Primary human monocyte culture as in vitro model of IFX pharmacokinetics: Influence of immunogenicity, immunosuppressive agents, albumin and inflammation. - Joana Afonso
  2. The role of gut microbiome, diet, and bile acid metabolism in IBD and in special IBD populations - exploring interactions that may predispose to special phenotypes. - Joana Torres
  3. The role of biliary salts malabsorption in inflammatory bowel disease: relationship with butyrate. - Mafalda Couto
  4. Genetics variations in FCGR3 receptors: implications in Infliximab therapeutics in inflammatory bowel disease. - Paula Serrão
  5. MGAT5 as a potential new gene determining severity in Inflammatory Bowel Disease. - Salomé Pinho
  6. Mesenchymal stem cells in inflamatory bowel disease: therapeutic strategy or cancer promoters? - Sergia Velho



2013

Bolsas 2013/14
  • 6 bolsas concedidas no valor de 15.000,00€

Projectos premiados:
  1. Perturbation of the intestinal barrier function in Inflammatory Bowel Diseases: role of the Rac1b /cytokine axis – PETER JORDAN
  2. Silent Myocardial Ischemia in Inflammatory Bowel Disease – TIAGO VIEIRA
  3. Oxidative Stress and DNA damage in Portuguese IBD patients – CRISTIANA COSTA PEREIRA
  4. O papel do glucagon-like peptide 2 e da dipeptidil peptidase 4/CD26 na Doença de Crohn – PEDRO LOPES
  5. Lack of response of infliximab in pediatric IBD patient – MARTA TAVARES
  6. Screening and monitoring of Epstein-Barr viremia in Patients with Inflammatory Bowel Diseases (IBD) under therapy (5-ASA, azathioprin, infliximab and infliximab plus azathioprin) and in healthy controls – CANDIDA ABREU


2012

Bolsa de Investigação GEDII 2012/13


 
Agenda
De 22 de Setembro a 24 de Setembro de 2021 Terminal de Cruzeiros do Porto de Leixões - Porto
Reunião Anual GEDII
©2021 GEDII - Grupo de Estudos da Doença Inflamatória Intestinal | Todos os direitos reservados | Links úteis | Termos e condiçoes
Desenvolvido por DogmaSis